CD5‐expressing CD8 + T‐cell subsets differ between children with type 1 diabetes and controls-Reference-Cited by-同舟云学术

CD5‐expressing CD8 + T‐cell subsets differ between children with type 1 diabetes and controls

Published:2021-07-18 Issue:10 Volume:99 Page:1077-1084
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Wadenpohl Josefine¹,Seyfarth Julia¹,Hehenkamp Paul¹,Hoffmann Maximilian¹,Kummer Sebastian¹,Reinauer Christina¹,Döing Carsten¹,Förtsch Katharina¹,Mayatepek Ertan¹,Meissner Thomas¹,Jacobsen Marc¹^ORCID

Affiliation:

1. Department of General Pediatrics, Neonatology and Pediatric Cardiology University Children’s Hospital Medical Faculty and University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Duesseldorf Germany

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12488

Reference20 articles.

1. CD5 Inhibits Signaling at the Immunological Synapse Without Impairing Its Formation

2. CD5 as a Target for Immune-Based Therapies

3. A Role for CD5 in TCR-Mediated Signal Transduction and Thymocyte Selection

4. Immunological Unresponsiveness Characterized by Increased Expression of CD5 on Peripheral T Cells Induced by Dendritic Cells In Vivo

5. Cutting Edge: Critical Role for CD5 in Experimental Autoimmune Encephalomyelitis: Inhibition of Engagement Reverses Disease in Mice

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic self-recognition-mediated TCR signal strength modulates antigen-specific CD8+ T cell pathogenicity in non-obese diabetic mice;2024-07-17

2. Thymic self-recognition-mediated TCR signal strength modulates antigen-specific CD8+ T cell pathogenicity in non-obese diabetic mice;2024-07-17

3. Thymic self-recognition-mediated TCR signal strength modulates antigen-specific CD8⁺T cell pathogenicity in non-obese diabetic mice;2024-06-12

4. Effects of Common Myokines on Diabetes Mellitus;Journal of Diabetes Mellitus;2022